Retropharyngeal Lymph Node Involvement in Oropharyngeal Carcinoma: Impact upon Risk of Distant Metastases and Survival Outcomes.

Published on Dec 29, 2019in Cancers6.126
· DOI :10.3390/CANCERS12010083
Zsuzsanna Iyizoba-Ebozue2
Estimated H-index: 2
,
Louise Murray18
Estimated H-index: 18
+ 4 AuthorsRobin Prestwich28
Estimated H-index: 28
Sources
Abstract
The influence of retropharyngeal lymph node (RPLN) involvement on prognosis in oropharyngeal carcinoma remains poorly defined. The aim of this study was to assess the impact of RPLN involvement upon outcomes. A single-centre retrospective analysis of 402 patients with oropharyngeal carcinoma treated nonsurgically between 2010 and 2017 was performed. All had a baseline 2-[fluorine-18]-fluoro-2-deoxy-d-glucose (FDG) PET-CT and contrast-enhanced MRI and/or CT. RPLN status was determined by radiology review of cases with reported abnormal RPLN. Multivariate backwards logistic regression was used to examine impact on outcomes of factors. Abnormal RPLNs were identified in 40/402 (10%) of patients. Median follow up was 42.9 months. RPLN involvement was associated with inferior 3 year outcomes for overall survival (OS) (67.1% vs. 79.1%, p = 0.006) and distant metastases-free survival (DMFS) (73.9% versus 88.0%, p = 0.011), with no significant difference in local control (81.6% vs. 87.7%, p = 0.154) or regional control (80.7% vs. 85.4%, p = 0.252). On multivariate analysis abnormal RPLN, no concurrent chemotherapy and ongoing smoking were associated with inferior DMFS and OS, while advanced T stage was also associated with inferior OS. In summary, RPLN involvement, present in 10% of patients, was an independent prognostic factor for the development of distant disease failure translating into inferior OS. These findings need confirmation in future studies.
📖 Papers frequently viewed together
20195.74Cancer
18 Authors (Timothy A. Lin, ..., G. Brandon Gunn)
10 Citations
7 Citations
20045.74Cancer
11 Authors (Jeannie Shen, ..., Gildy V. Babiera)
89 Citations
References41
Newest
#2Louise Murray (University of Leeds)H-Index: 18
Last. Robin PrestwichH-Index: 28
view all 6 authors...
Abstract Introduction The aim was to evaluate in oropharyngeal carcinoma the: (1) incidence and predictors of retropharyngeal (RP) lymph node (LN) involvement, (2) pattern of ipsilateral/bilateral/contralateral-only RP LNs (3) location of RP LNs in relation to contouring guidelines. Methods Single centre retrospective analysis of 402 patients with oropharyngeal carcinoma treated non-surgically between 2010 and 2017. All patients had a baseline FDG PET-CT and contrast-enhanced MRI and/or CT. All ...
5 CitationsSource
4 CitationsSource
#1Timothy A. Lin (BCM: Baylor College of Medicine)H-Index: 6
#2Adam S. Garden (University of Texas MD Anderson Cancer Center)H-Index: 93
Last. G. Brandon Gunn (University of Texas MD Anderson Cancer Center)H-Index: 30
view all 18 authors...
BACKGROUND: The objective of the current study was to characterize the incidence, pattern, and impact on oncologic outcomes of retropharyngeal lymph node (RPLN) involvement in HPV-associated oropharyngeal cancer (OPC). METHODS: Data regarding patients with HPV-associated OPC who were treated at The University of Texas MD Anderson Cancer Center with intensity-modulated radiotherapy from 2004 through 2013 were analyzed retrospectively. RPLN status was determined by reviewing pretreatment imaging a...
10 CitationsSource
#1Astrid Billfalk-Kelly (Princess Margaret Cancer Centre)H-Index: 2
#2Eugene Yu (Princess Margaret Cancer Centre)H-Index: 9
Last. Shao Hui Huang (Princess Margaret Cancer Centre)H-Index: 33
view all 21 authors...
Purpose To identify adverse radiologic nodal features in cN+ TNM-8 stage I human papillomavirus–related (HPV+) oropharyngeal cancer (OPC). Methods and Materials All patients with HPV+ cT1-T2cN1 OPC treated with definitive intensity modulated radiation therapy from 2008 to 2015 were included. Radiologically involved lymph node number (LN), radiologic extranodal extension (rENE), retropharyngeal LN (RPLN), and lower neck (level 4 or 5b) LN involvement were assessed on pre-treatment computed tomogr...
20 CitationsSource
#1Maura L. Gillison (University of Texas MD Anderson Cancer Center)H-Index: 22
#2Andy TrottiH-Index: 56
Last. Quynh-Thu Le (Stanford University)H-Index: 81
view all 27 authors...
Summary Background Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether replacement of cisplatin with cetuximab—an antibody against the epidermal growth factor receptor—can preserve high survival and reduce treatment toxicity is unknown. We investigated whether cetuximab would maintain a high proportion of patient survival and reduce acute and late toxicity. Methods RTOG 1016 was a random...
317 CitationsSource
#1Hisham Mehanna (University of Birmingham)H-Index: 44
#2Max Robinson (Newcastle University)H-Index: 49
Last. Catharine H. ClarkH-Index: 26
view all 62 authors...
Summary Background The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal growth factor receptor inhibitor, has been proposed for treatment de-escalation in this setting to reduce the toxicity of standard cisplatin treatment, but no randomised evidence exists for the efficacy of this strategy. Methods We did an open-label randomised controlled phase 3 trial at 32 head and neck treatment centr...
271 CitationsSource
Abstract HPV-driven oropharyngeal cancers have significantly better survival rates than tobacco and alcohol induced head and neck cancers. As HPV-positive patients are younger, healthier and far more likely to survive their disease, long-term treatment side effects are becoming a major issue. This has led the scientific and medical community to reassess the current treatment protocols in order to develop less toxic strategies while maintaining good oncological outcomes. In this article, we discu...
88 CitationsSource
#1Farhoud Faraji (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 19
#2David W. Eisele (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 67
Last. Carole Fakhry (Johns Hopkins University)H-Index: 37
view all 3 authors...
Objective To review recent literature on human papillomavirus-related (HPV-positive) oropharyngeal squamous cell carcinoma (OPC) and focus on implications of recurrent and metastatic disease. Methods Primary articles from 1990 to 2016 indexed in MEDLINE (1) pertaining to the epidemiology of HPV-positive OPC and (2) providing clinical insight into recurrent and metastatic OPC. Results The incidence of HPV-positive OPC is increasing globally. HPV-positive OPC is a subtype with distinct molecular a...
20 CitationsSource
#1Matthew E. Spector (UM: University of Michigan)H-Index: 26
#2Steven B. Chinn (UM: University of Michigan)H-Index: 17
Last. Douglas B. Chepeha (UM: University of Michigan)H-Index: 60
view all 15 authors...
Importance Understanding the drainage patterns to the retropharyngeal lymph nodes is an important consideration in oropharyngeal squamous cell carcinoma (OPSCC) because treatment of these nodes is related to increased morbidity. Prediction of these drainage patterns could not only help minimize treatment morbidity but also prevent failures in at-risk patients as deintensification trials are under way for this disease. Objective To evaluate the prevalence of pathologic retropharyngeal adenopathy ...
6 CitationsSource
#1Michael Baxter (NMCSD: Naval Medical Center San Diego)H-Index: 3
#2Jason Y. K. Chan (Johns Hopkins University)H-Index: 20
Last. Agrawal Nishant (Johns Hopkins University)H-Index: 1
view all 8 authors...
Objectives/Hypothesis The purpose of this study was to retrospectively review patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (OPSCC) for the presence of retropharyngeal lymph nodes (RPLNs) prior to treatment using positron emission tomography/computed tomography (PET/CT), and to determine if the presence of RPLNs is of utility in predicting outcomes. Study Design Retrospective review of patient data from a single institution. Methods Two hundred thirty ...
13 CitationsSource
Cited By2
Newest
#1O. BhattasaliH-Index: 6
#2Fernando A. TorresH-Index: 2
Last. S. IganejH-Index: 6
view all 10 authors...
Abstract Objectives We analyzed the prognostic impact of retropharyngeal lymphadenopathy (RPL) in stage I node-positive HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods We performed a centralized and blinded radiographic review of the pre-treatment images of 234 consecutive patients with AJCC 8th edition stage I cT1-2N1 HPV-associated OPSCC treated with definitive chemoradiation from 2006 to 2016. Five-year disease control and survival outcomes were reported. T...
Source
#1Smriti Panda (AIIMS: All India Institute of Medical Sciences)H-Index: 5
#2Alok Thakar (AIIMS: All India Institute of Medical Sciences)H-Index: 24
Last. Suresh C. Sharma (AIIMS: All India Institute of Medical Sciences)H-Index: 11
view all 7 authors...
Purpose Tonsil cancer being predominantly treated by non-surgical means, there is a paucity of data on lymph nodal drainage pathways and histo-pathologically confirmed metastatic rates. This study assesses the retropharyngeal lymph node (RPLN) in N0 squamous cell carcinoma tonsil as a possible first echelon node and a site for occult metastasis. Methods Prospective study involving treatment naive N0 carcinoma tonsil treated by primary surgery and adjuvant treatment from June 2017 to March 2019. ...
Source